Viewing Study NCT01707394


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-06-27 @ 8:02 AM
Study NCT ID: NCT01707394
Status: COMPLETED
Last Update Posted: 2021-03-22
First Post: 2012-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module